NDC 0430-3754

ESTRACE

Estradiol

ESTRACE is a Vaginal Cream in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Estradiol.

Product ID0430-3754_2e1d916c-1443-4349-9695-572e4e662983
NDC0430-3754
Product TypeHuman Prescription Drug
Proprietary NameESTRACE
Generic NameEstradiol
Dosage FormCream
Route of AdministrationVAGINAL
Marketing Start Date2001-07-01
Marketing CategoryANDA / ANDA
Application NumberANDA086069
Labeler NameAllergan, Inc.
Substance NameESTRADIOL
Active Ingredient Strength0 mg/g
Pharm ClassesEstradiol Congeners [CS],Estrogen [EPC],Estrogen Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0430-3754-14

36 CARTON in 1 CASE (0430-3754-14) > 1 TUBE, WITH APPLICATOR in 1 CARTON > 42.5 g in 1 TUBE, WITH APPLICATOR
Marketing Start Date2001-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0430-3754-14 [00430375414]

ESTRACE CREAM
Marketing CategoryANDA
Application NumberANDA086069
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2001-07-01

NDC 0430-3754-95 [00430375495]

ESTRACE CREAM
Marketing CategoryANDA
Application NumberANDA086069
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2001-07-01
Marketing End Date2017-05-11

Drug Details

Active Ingredients

IngredientStrength
ESTRADIOL.1 mg/g

OpenFDA Data

SPL SET ID:dfc41fcd-c5ba-4b25-b647-cf04d3988b3e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310169
  • 890918
  • Pharmacological Class

    • Estradiol Congeners [CS]
    • Estrogen [EPC]
    • Estrogen Receptor Agonists [MoA]

    NDC Crossover Matching brand name "ESTRACE" or generic name "Estradiol"

    NDCBrand NameGeneric Name
    0430-0722EstraceEstrace
    0430-0720EstraceEstrace
    0430-0721EstraceEstrace
    0430-3754ESTRACEESTRACE
    50090-2321ESTRACEESTRACE
    0023-5885AloraEstradiol
    0023-5886AloraEstradiol
    0023-5887AloraEstradiol
    0023-5888AloraEstradiol
    0037-4801ELESTRINESTRADIOL
    0037-4802ELESTRINESTRADIOL
    0013-2150Estringestradiol
    0078-0343Vivelle-Dotestradiol
    0078-0344Vivelle-Dotestradiol
    0078-0345Vivelle-Dotestradiol
    0078-0346Vivelle-Dotestradiol
    0078-0365Vivelle-Dotestradiol

    Trademark Results [ESTRACE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ESTRACE
    ESTRACE
    72454618 0976274 Live/Registered
    MEAD JOHNSON & COMPANY
    1973-04-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.